CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company
Neumora Therapeutics, Inc.
Sign in to watch- Ticker
- NMRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844367680
- Phone
- (857) 760-0900
- Business address
- 260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $481,506
- in 2 filings
Net −$481,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-13 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +28,571 | 28,571 | ||
| 2024-06-13 | Piacquad David Director | Grant or award | +20,100 | 20,100 | ||
| 2024-06-13 | Piacquad David Director | Grant or award · Stock Option (Right to Buy) | +28,571 | 28,571 | ||
| 2024-06-13 | Halawa Alaa Director | Grant or award | +20,100 | 20,100 | ||
| 2024-06-13 | Halawa Alaa Director | Grant or award · Stock Option (Right to Buy) | +28,571 | 28,571 | ||
| 2024-06-13 | Fust Matthew K Director | Grant or award | +20,100 | 20,100 | ||
| 2024-06-13 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +28,571 | 28,571 | ||
| 2024-06-13 | Burow Kristina Director | Grant or award | +20,100 | 47,717 | ||
| 2024-06-13 | Burow Kristina Director | Grant or award · Stock Option (Right to Buy) | +28,571 | 28,571 | ||
| 2024-04-22 | Aurora Daljit Singh Chief Strategy Officer | Gift | −114,703 | 97,500 | ||
| 2024-04-17 | Pinto Joshua Chief Financial Officer | Gift | −238,965 | 238,965 | ||
| 2024-02-14 | Pinto Joshua Chief Financial Officer | Grant or award | +85,000 | 323,965 | ||
| 2024-02-14 | Pinto Joshua Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2024-02-14 | Aurora Daljit Singh Chief Strategy Officer | Grant or award | +97,500 | 212,203 | ||
| 2024-02-14 | Aurora Daljit Singh Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +195,000 | 195,000 | ||
| 2024-02-14 | Suh Carol Y. Chief Operating Officer | Grant or award | +85,000 | 374,674 | ||
| 2024-02-14 | Suh Carol Y. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2024-02-14 | BERNS PAUL L Director | Grant or award | +171,250 | 7,818,166 | ||
| 2024-02-14 | BERNS PAUL L Director | Grant or award · Stock Option (Right to Buy) | +342,500 | 342,500 | ||
| 2024-02-14 | Gosebruch Henry O President & CEO | Grant or award | +80,000 | 462,345 |
Page 14 of 20 · 384 trades